Results 171 to 180 of about 3,933 (191)

New drug overview. Pioglitazone hydrochloride

American Journal of Health-System Pharmacy, 2000
openaire   +2 more sources

Estimation of Metformin Hydrochloride, Gliclazide and Pioglitazone Hydrochloride: A UDDD-HPTLC Densitometry Method Validation Study

2023
Rajesh Varade, Harsha Mishra
openaire   +1 more source

Assessment of Related Substances in Pioglitazone Hydrochloride by HPLC Method

2022
N. Balaji, Sayeeda Sultana
openaire   +1 more source

Spectrophotometric methods for determination of glimepiride and pioglitazone hydrochloride mixture and application in their pharmaceutical formulation

Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2022
Maha A Hegazy
exaly  

Combination chemotherapy against colorectal cancer cells: Co-delivery of capecitabine and pioglitazone hydrochloride by polycaprolactone-polyethylene glycol carriers

Life Sciences, 2023
Fahima Danesh Pouya, Roya Salehi, Yousef Rasmi   +2 more
exaly  

Precipitation of Pioglitazone Hydrochloride Microparticles by Supercritical Anti-Solvent (SAS)

British Journal of Pharmaceutical Research, 2015
Seyyed Razavipour, Kiarash Keshmiri, Alireza Vatanara, Mostafa Hajmohammadi   +3 more
openaire   +1 more source

Preferential solvation of pioglitazone hydrochloride in some binary co-solvent mixtures according to the inverse Kirkwood–Buff integrals method

Journal of Chemical Thermodynamics, 2017
Xinbao Li
exaly  

Pioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes mellitus: A randomized, placebo-controlled study

Clinical Therapeutics, 2000
Marc S Rendell
exaly  

Effects of pioglitazone hydrochloride and vitamin E on meat quality, antioxidant status and fatty acid profiles in finishing pigs

Meat Science, 2018
Cheng-Long Jin, Chun-Qi Gao, Hai-Chang Li   +2 more
exaly  

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

Lancet, The, 2005
Erland Erdmann, Eberhard Standl, Kåre I Birkeland   +2 more
exaly